Navigation Links
Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
Date:10/28/2013

LA JOLLA, Calif., Oct. 28, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of an undisclosed oncology target by AstraZeneca under the strategic alliance to discover, develop, and commercialize microRNA therapeutics.  Regulus and AstraZeneca continue to collaborate on three exclusive microRNA targets in cardiovascular and metabolic diseases and oncology.

"We are very pleased with the successful relationship we have built with AstraZeneca and their selection of a validated microRNA target for oncology indications," said Neil W. Gibson, Ph.D., Chief Scientific Officer of Regulus.  "In the last year, we have made significant progress in advancing our drug discovery efforts against the portfolio of AstraZeneca targets.  With the support of AstraZeneca's drug development expertise and commitment to the RNA therapeutics field, we continue to harness our microRNA expertise to develop innovative, first-in-class treatment options for patients in need." 

In August 2012, Regulus and AstraZeneca formed a strategic alliance focused on three exclusive microRNA targets for cardiovascular and metabolic diseases and oncology, which includes Regulus' program targeting microRNA-33 for the treatment of atherosclerosis.  Under the terms of the alliance, Regulus will lead preclinical development and, if successful, could receive preclinical milestone payments.  AstraZeneca will lead and fund the clinical development and commercialization of these programs.  In addition, Regulus could also receive clinical milestones based on the successful development of microRNA therapies in each target area. Regulus is also eligible to receive significant launch
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
2. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
3. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
4. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
5. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
6. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
7. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
8. Regulus to Present at Future Leaders in the Biotech Industry Conference
9. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
10. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
11. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014   Reproductive Medicine ... leader in the field of infertility, presents new ... embryonic screening. The research abstract, released during the ... Medicine (ASRM) meeting in Honolulu, Hawaii ... single gene defect (SGD) pre-implantation genetic diagnosis (PGD). ...
(Date:10/22/2014)... -- AVACEN Medical announced today that its AVACEN 100 ... by the U.S. Food and Drug Administration. This clearance ... Internet for: the temporary relief of joint pain ... sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... a sophisticated medical device incorporating over 3,000 firmware instructions ...
(Date:10/22/2014)... 2014  With a vision to ensure safety ... Global Pharmaceutical and Biotech manufacturer selects and implements ... solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... aggregated by the Xyntek and Antares solution is ...
Breaking Medicine Technology:New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Xyntek and Antares Serialization Solution Protects Pets Too! 2
... A Commonwealth Fund case study notes that ... aligned "to launch innovations and organize services in ways that make ... study -- along other profiles looking at medical systems that have ... high performing health care system -- has been in the works ...
... Conatus Pharmaceuticals Inc. announced today the initiation of a ... for the treatment of liver disease associated with Hepatitis C ... treatment with approved standard of care treatments is not currently ... patients who failed standard of care treatment are expected to ...
Cached Medicine Technology:Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative 2Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative 3Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis 2
(Date:10/22/2014)... October 22, 2014 Shriners Hospitals for ... will change the current location of Shriners Hospitals for ... Limestone across from the University of Kentucky Albert B. ... ambulatory care center, owned and operated by Shriners Hospitals ... needs of children and their families well into the ...
(Date:10/22/2014)... During the Western United States’ worst ever ... low, Southern Oregon’s water is proving resistant to drought ... mountain snow pack on record in 2014, remain high ... That was the observation of journalist-hikers Art Bernstein and ... Oregon,” during an interview with water advocate Sharon Kleyne.† ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... be showing a genetic propensity for obesity as toddlers, a ... linked to increased body fat, but the same genes in ... researchers said. At 1 year, kids with these genes ... however, these genes were linked to excessive weight gain, the ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... crucial part of conventional in vitro fertilization (IVF) -- the ... take place in a device inside the vagina, new research ... that the device, called an INVOcell, might sharply cut costs ... make the technology more accessible to those who don,t live ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... June 4 Martek Biosciences,(Nasdaq: MATK ) ... DHA omega-3 for brain, eye and heart health, ... mainstream grocery retailers,across the U.S. WhiteWave Foods launched ... in 2007 and it is now the fastest,growing ...
... June 4 DTC Perspectives, Inc. is,proud to introduce ... award will,honor and recognize individuals who have made significant ... demonstrated,a record of extraordinary achievement in DTC marketing., ... up to five individuals,will be inducted and announced. The ...
... few key locations, such as work and home , , WEDNESDAY, ... track movement, a new study suggests that people are creatures ... and remaining at -- a few key locations, such as ... to analyzing human mobility appears to be more accurate, easier, ...
... of rotavirus vaccines, ISTANBUL, Turkey, June 4 ... policymakers and leading public health,professionals from 67 countries ... Istanbul, Turkey, to present new data about,rotavirus -- ... leads to death,among young children., "Regardless of ...
... supportive policies and public research dollars, the United Kingdom, ... shares of human embryonic stem cell research, according to ... the June 2008 issue Cell Stem Cell. Aaron Levine, ... book Cloning: A Beginner,s Guide, studied how countries output ...
... June 4 BasicPlus Health,Insurance of Roswell, Ga., ... with Companion Global Healthcare Inc. of Columbia, S.C., ... its most popular,limited benefit health insurance plans., ... (for,employers) and BasicPlus (for individuals) limited benefit plans ...
Cached Medicine News:Health News:Martek's life'sDHA(TM) Now Available in Rachel's(TM) Yogurt at Grocery Retailers Nationwide 2Health News:Martek's life'sDHA(TM) Now Available in Rachel's(TM) Yogurt at Grocery Retailers Nationwide 3Health News:DTC Perspectives, Inc. Announces the New DTC Hall of Fame Award 2Health News:Cell Phone Study Suggests People Are Losing Their Wanderlust 2Health News:Cell Phone Study Suggests People Are Losing Their Wanderlust 3Health News:World's Leading Health Experts Urge Countries to Use Newly Released Data to Prevent the Death of Millions of Children Due to Rotavirus 2Health News:Public funding impacts progress of human embryonic stem cell research 2Health News:Public funding impacts progress of human embryonic stem cell research 3Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3
... Propel Cannulated Interference Screw ... unbiased, symmetrical starts, while limiting ... distal end reduces abrasion where ... unequalled protection. Aggressive-pitch thread enables ...
Cannulated Interference Screws...
Cannulated Interference Screws...
... CoEase is designed to provide excellent protection ... unique advantage of being closer to an ... This allows CoEase to maintain viscosity ... best of both worlds for superb performance ...
Medicine Products: